THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis
Europe - FRA:TN8 - US8835561023 - Common Stock
411.75 EUR
-6.55 (-1.57%)
Taking everything into account, TN8 scores 5 out of 10 in our fundamental rating. TN8 was compared to 18 industry peers in the Life Sciences Tools & Services industry. While TN8 has a great profitability rating, there are some minor concerns on its financial health. TN8 is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
TN8 had positive earnings in the past year.
In the past year TN8 had a positive cash flow from operations.
In the past 5 years TN8 has always been profitable.
In the past 5 years TN8 always reported a positive cash flow from operatings.
1.2 Ratios
TN8 has a Return On Assets of 6.50%. This is amongst the best in the industry. TN8 outperforms 83.33% of its industry peers.
TN8 has a Return On Equity of 13.04%. This is amongst the best in the industry. TN8 outperforms 88.89% of its industry peers.
TN8's Return On Invested Capital of 6.25% is fine compared to the rest of the industry. TN8 outperforms 61.11% of its industry peers.
TN8 had an Average Return On Invested Capital over the past 3 years of 6.66%. This is in line with the industry average of 7.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.5% | ||
| ROE | 13.04% | ||
| ROIC | 6.25% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
1.3 Margins
The Profit Margin of TN8 (15.24%) is better than 83.33% of its industry peers.
TN8's Profit Margin has been stable in the last couple of years.
TN8 has a better Operating Margin (18.18%) than 72.22% of its industry peers.
In the last couple of years the Operating Margin of TN8 has grown nicely.
TN8 has a Gross Margin (41.34%) which is in line with its industry peers.
In the last couple of years the Gross Margin of TN8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.18% | ||
| PM (TTM) | 15.24% | ||
| GM | 41.34% |
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TN8 is destroying value.
TN8 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, TN8 has less shares outstanding
The debt/assets ratio for TN8 has been reduced compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of TN8 is 5.71, which is a neutral value as it means it would take TN8, 5.71 years of fcf income to pay off all of its debts.
TN8 has a Debt to FCF ratio (5.71) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.65 indicates that TN8 is somewhat dependend on debt financing.
TN8's Debt to Equity ratio of 0.65 is in line compared to the rest of the industry. TN8 outperforms 55.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.71 | ||
| Altman-Z | N/A |
ROIC/WACC0.63
WACC9.87%
2.3 Liquidity
A Current Ratio of 1.93 indicates that TN8 should not have too much problems paying its short term obligations.
TN8's Current ratio of 1.93 is amongst the best of the industry. TN8 outperforms 88.89% of its industry peers.
TN8 has a Quick Ratio of 1.50. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of TN8 (1.50) is better than 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.23% over the past year.
The Earnings Per Share has been growing by 12.12% on average over the past years. This is quite good.
The Revenue has been growing slightly by 2.05% in the past year.
Measured over the past years, TN8 shows a quite strong growth in Revenue. The Revenue has been growing by 10.92% on average per year.
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%
3.2 Future
The Earnings Per Share is expected to grow by 9.36% on average over the next years. This is quite good.
Based on estimates for the next years, TN8 will show a small growth in Revenue. The Revenue will grow by 4.55% on average per year.
EPS Next Y3.98%
EPS Next 2Y6.16%
EPS Next 3Y7.53%
EPS Next 5Y9.36%
Revenue Next Year2.69%
Revenue Next 2Y3.73%
Revenue Next 3Y4.43%
Revenue Next 5Y4.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 22.04, the valuation of TN8 can be described as rather expensive.
Based on the Price/Earnings ratio, TN8 is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, TN8 is valued at the same level.
A Price/Forward Earnings ratio of 19.58 indicates a rather expensive valuation of TN8.
61.11% of the companies in the same industry are more expensive than TN8, based on the Price/Forward Earnings ratio.
TN8 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.04 | ||
| Fwd PE | 19.58 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TN8 is on the same level as its industry peers.
TN8's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.53 | ||
| EV/EBITDA | 19.5 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TN8 does not grow enough to justify the current Price/Earnings ratio.
TN8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.54
PEG (5Y)1.82
EPS Next 2Y6.16%
EPS Next 3Y7.53%
5. Dividend
5.1 Amount
With a yearly dividend of 0.35%, TN8 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.73, TN8 is paying slightly less dividend.
With a Dividend Yield of 0.35, TN8 pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
5.2 History
The dividend of TN8 is nicely growing with an annual growth rate of 15.37%!
Dividend Growth(5Y)15.37%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
TN8 pays out 9.26% of its income as dividend. This is a sustainable payout ratio.
The dividend of TN8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP9.26%
EPS Next 2Y6.16%
EPS Next 3Y7.53%
FRA:TN8 (9/12/2025, 7:00:00 PM)
411.75
-6.55 (-1.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners92.18%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap155.48B
Analysts81.14
Price Target475.03 (15.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
Yearly Dividend1.29
Dividend Growth(5Y)15.37%
DP9.26%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.77%
Min EPS beat(2)-0.07%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)0.72%
Min EPS beat(4)-0.34%
Max EPS beat(4)1.69%
EPS beat(8)5
Avg EPS beat(8)1.74%
EPS beat(12)7
Avg EPS beat(12)1.2%
EPS beat(16)11
Avg EPS beat(16)5.31%
Revenue beat(2)2
Avg Revenue beat(2)0.45%
Min Revenue beat(2)0.28%
Max Revenue beat(2)0.62%
Revenue beat(4)3
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.62%
Revenue beat(8)5
Avg Revenue beat(8)-0.15%
Revenue beat(12)7
Avg Revenue beat(12)0.84%
Revenue beat(16)11
Avg Revenue beat(16)3.32%
PT rev (1m)-1.76%
PT rev (3m)-6.77%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)-4.71%
EPS NY rev (1m)0.77%
EPS NY rev (3m)0.87%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)0.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.04 | ||
| Fwd PE | 19.58 | ||
| P/S | 4.22 | ||
| P/FCF | 29.53 | ||
| P/OCF | 24.04 | ||
| P/B | 3.61 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.5 |
EPS(TTM)18.68
EY4.54%
EPS(NY)21.03
Fwd EY5.11%
FCF(TTM)13.94
FCFY3.39%
OCF(TTM)17.13
OCFY4.16%
SpS97.66
BVpS114.07
TBVpS-26.94
PEG (NY)5.54
PEG (5Y)1.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.5% | ||
| ROE | 13.04% | ||
| ROCE | 8.88% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 28.04% | ||
| OM | 18.18% | ||
| PM (TTM) | 15.24% | ||
| GM | 41.34% | ||
| FCFM | 14.28% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexcg growth 3Y-8.22%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
F-Score7
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.71 | ||
| Debt/EBITDA | 3.08 | ||
| Cap/Depr | 49.03% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 70.63% | ||
| Profit Quality | 93.71% | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | N/A |
F-Score7
WACC9.87%
ROIC/WACC0.63
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
EPS Next Y3.98%
EPS Next 2Y6.16%
EPS Next 3Y7.53%
EPS Next 5Y9.36%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%
Revenue Next Year2.69%
Revenue Next 2Y3.73%
Revenue Next 3Y4.43%
Revenue Next 5Y4.55%
EBIT growth 1Y5.17%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year13.42%
EBIT Next 3Y8.96%
EBIT Next 5Y8.68%
FCF growth 1Y5.4%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-1.49%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%